Boc-E-FMK merges a Boc-protected glutamate with an FMK reactive center, forming a minimal substrate analog. The molecule informs studies of side-chain charge effects on protease engagement. Researchers use it to probe catalytic pocket electrostatics and irreversible inhibition. Its simple framework supports detailed mechanistic and synthetic analyses.
CAT No: HB00054
Boc-E-FMK, or tert-Butyloxycarbonyl-L-glutamyl fluoromethyl ketone, is a synthetic peptide-based inhibitor widely utilized in biochemical research for its potent and selective irreversible inhibition of cysteine proteases, particularly caspases. As a modified dipeptidyl fluoromethyl ketone, it features a Boc-protected glutamic acid residue, which enhances its stability and membrane permeability, making it a valuable tool for dissecting protease-mediated cellular processes. Its application is especially prominent in studies focused on programmed cell death, signal transduction, and protease function, where precise modulation of enzymatic activity is essential for elucidating complex biological pathways.
Protease inhibition studies: Boc-E-FMK serves as a highly effective irreversible inhibitor for cysteine proteases, especially caspases, which play pivotal roles in apoptosis and inflammation. By covalently modifying the active site cysteine residue of target enzymes, the compound enables researchers to selectively block proteolytic activity. This property is instrumental for mapping protease substrate specificity, validating protease involvement in cellular pathways, and distinguishing between overlapping enzymatic functions in complex biological systems.
Apoptosis research: The compound is extensively applied in the investigation of programmed cell death mechanisms. By selectively inhibiting caspase activity, Boc-E-FMK allows scientists to dissect the sequential events and regulatory checkpoints that govern apoptosis. Its use facilitates the differentiation of caspase-dependent and caspase-independent pathways, providing critical insights into cell fate determination, stress responses, and the molecular basis of tissue remodeling or degeneration.
Cell signaling pathway analysis: In studies exploring intracellular signaling, Boc-E-FMK is employed to interrogate the role of proteolytic events in signal transduction cascades. By preventing specific protease-mediated cleavage events, it helps clarify how proteases modulate the activation or inactivation of signaling proteins, transcription factors, and other regulatory molecules. This approach is valuable for identifying novel protease substrates and for unraveling the dynamics of cellular responses to stimuli.
Functional proteomics: The irreversible binding mechanism of Boc-E-FMK enables its use in activity-based protein profiling (ABPP) and related proteomic techniques. By forming stable adducts with active cysteine proteases, the compound can be used to tag and isolate these enzymes from complex biological samples. This facilitates the identification, quantification, and characterization of active protease populations under various experimental conditions, enhancing our understanding of protease regulation in health and disease.
Peptide inhibitor development: As a model compound, Boc-E-FMK provides a structural and mechanistic framework for the design and synthesis of novel peptide-based protease inhibitors. Its chemical features, such as the fluoromethyl ketone warhead and Boc-protected side chain, inform medicinal chemistry efforts aimed at optimizing selectivity, potency, and bioavailability. Researchers leverage these attributes to develop next-generation inhibitors for research applications in enzymology, cell biology, and drug discovery.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.